StockData
Pro Dex Inc logo

Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3010% below fair value
$63.94+2.01 (+3.25%)

Close on Nov 18, 2026Market cap $204.61MP/E 17.6Yield –

Pro Dex free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Pro Dex's free cash flow for the twelve months ending Sep 30, 2026 was $10.69M. For fiscal 2026 it was $6.76M. The highest annual figure on record is $6.76M in fiscal 2026.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$6.76M–
FY2025Jun 30, 2025-$2.93M–
FY2022Jun 30, 2022-$2.49M–
FY2021Jun 30, 2021-$3.85M-186.9%
FY2020Jun 30, 2020$4.43M+128.3%
FY2019Jun 30, 2019$1.94M-10.8%
FY2018Jun 30, 2018$2.17M-17.3%
FY2017Jun 30, 2017$2.63M+1596.1%
FY2016Jun 30, 2016$155.00K–
FY2015Jun 30, 2015-$1.02M–
FY2014Jun 30, 2014-$379.00K–
FY2013Jun 30, 2013-$1.36M–
FY2012Jun 30, 2012-$296.00K-111.2%
FY2011Jun 30, 2011$2.63M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$6.14M+177.8%
Q4 FY2026CQ2 2026Jun 30, 2026-$476.00K–
Q3 FY2026CQ1 2026Mar 31, 2026$1.52M+165.0%
Q2 FY2026CQ4 2025Dec 31, 2025$3.50M–
Q1 FY2026CQ3 2025Sep 30, 2025$2.21M+51.9%
Q4 FY2025CQ2 2025Jun 30, 2025-$266.00K-106.7%
Q3 FY2025CQ1 2025Mar 31, 2025$574.00K+645.5%
Q2 FY2025CQ4 2024Dec 31, 2024-$4.69M-1863.9%
Q1 FY2025CQ3 2024Sep 30, 2024$1.46M-33.9%
Q3 FY2024CQ1 2024Mar 31, 2024$3.96M–
Q2 FY2024CQ4 2023Dec 31, 2023$77.00K-97.2%
Q1 FY2024CQ3 2023Sep 30, 2023$266.00K–
Q3 FY2023CQ1 2023Mar 31, 2023$2.20M+14586.7%
Q2 FY2023CQ4 2022Dec 31, 2022-$904.00K-169.9%
Q1 FY2023CQ3 2022Sep 30, 2022$2.71M+46.5%
Q4 FY2022CQ2 2022Jun 30, 2022-$5.65M–
Q3 FY2022CQ1 2022Mar 31, 2022$15.00K–
Q2 FY2022CQ4 2021Dec 31, 2021$1.29M-25.9%
Q1 FY2022CQ3 2021Sep 30, 2021$1.85M–
Q4 FY2021CQ2 2021Jun 30, 2021-$172.00K-106.7%
Q3 FY2021CQ1 2021Mar 31, 2021-$4.44M–
Q2 FY2021CQ4 2020Dec 31, 2020$1.75M+25.3%
Q1 FY2021CQ3 2020Sep 30, 2020-$977.00K-215.3%
Q4 FY2020CQ2 2020Jun 30, 2020$2.55M–
Q3 FY2020CQ1 2020Mar 31, 2020-$365.00K-134.1%
Q2 FY2020CQ4 2019Dec 31, 2019$1.39M+72.3%
Q1 FY2020CQ3 2019Sep 30, 2019$847.00K+432.7%
Q4 FY2019CQ2 2019Jun 30, 2019-$98.00K-108.1%
Q3 FY2019CQ1 2019Mar 31, 2019$1.07M+182.1%
Q2 FY2019CQ4 2018Dec 31, 2018$809.00K–
Q1 FY2019CQ3 2018Sep 30, 2018$159.00K-82.8%
Q4 FY2018CQ2 2018Jun 30, 2018$1.20M-4.5%
Q3 FY2018CQ1 2018Mar 31, 2018$379.00K-61.5%
Q2 FY2018CQ4 2017Dec 31, 2017-$332.00K-174.6%
Q1 FY2018CQ3 2017Sep 30, 2017$922.00K–
Q4 FY2017CQ2 2017Jun 30, 2017$1.26M–
Q3 FY2017CQ1 2017Mar 31, 2017$984.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$445.00K–

More Pro Dex figures

See a number that looks wrong?